Activity of tigecycline against recent European clinical isolates of Clostridium difficile

被引:16
作者
Hawser, Stephen P. [1 ]
机构
[1] IHMA Europe Sarl, CH-1066 Epalinges, Switzerland
关键词
INFECTION;
D O I
10.1016/j.ijantimicag.2009.09.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:97 / 98
页数:3
相关论文
共 6 条
[1]  
CLSI, 2008, M100S18 CLSI
[2]  
CLSI, 2007, M11A7 CLSI
[3]   What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile? [J].
Coia, John E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 :S9-S12
[4]   Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection [J].
Herpers, Bjorn L. ;
Vlaminckx, Bart ;
Burkhardt, Olaf ;
Blom, Harmjo ;
Biemond-Moeniralam, Hazra S. ;
Hornef, Mathias ;
Welte, Tobias ;
Kuijper, Edward J. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) :1732-1735
[5]   Clostridium difficile is no longer just a nosocomial infection or an infection of adults [J].
Pituch, Hanna .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 :S42-S45
[6]  
TYGACIL PRODUCT MONO